Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SQZ
2951
DELISTED
SQZ Biotechnologies Company
SQZ
| $811K | ﹤0.01% |
56,180
-27,266
| -33% | -$370K |
|
2952
Cato Corp
CATO
$65.9M
| $810K | ﹤0.01% |
48,990
-86,932
| -64% | -$1.45M |
|
|
IEA
2953
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $809K | ﹤0.01% |
70,717
+22,770
| +47% | +$280K |
|
2954
Gaia
GAIA
$30.8M
| $806K | ﹤0.01% |
84,982
-6,496
| -7% | -$68.5K |
|
2955
Peoples Financial Services
PFIS
$713M
| $806K | ﹤0.01% |
17,683
-28,741
| -62% | -$1.28M |
|
2956
Coastal Financial
CCB
$772M
| $804K | ﹤0.01% |
25,234
+1,800
| +8% | +$53.6K |
|
2957
Tilly's
TLYS
$124M
| $803K | ﹤0.01% |
57,253
+3,629
| +7% | +$55.1K |
|
2958
ANI Pharmaceuticals
ANIP
$1.7B
| $802K | ﹤0.01% |
24,440
-44,853
| -65% | -$1.39M |
|
2959
Citizens
CIA
$198M
| $800K | ﹤0.01% |
128,708
-192,302
| -60% | -$1.09M |
|
2960
Select Water Solutions
WTTR
$2.73B
| $798K | ﹤0.01% |
153,755
-267,522
| -64% | -$1.47M |
|
2961
SoundThinking
SSTI
$106M
| $796K | ﹤0.01% |
21,871
-71
| -0.3% | -$2.98K |
|
|
INDT
2962
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $796K | ﹤0.01% |
11,350
-15
| -0.1% | -$1.02K |
|
2963
Lineage Cell Therapeutics
LCTX
$278M
| $795K | ﹤0.01% |
315,354
-7,007
| -2% | -$18K |
|
|
STXB
2964
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $794K | ﹤0.01% |
32,787
| – | – |
|
|
MSON
2965
DELISTED
Misonix Inc
MSON
| $793K | ﹤0.01% |
31,322
| – | – |
|
2966
Intrepid Potash
IPI
$494M
| $791K | ﹤0.01% |
25,588
| – | – |
|
2967
Spyre Therapeutics
SYRE
$9.22B
| $791K | ﹤0.01% |
3,979
-252
| -6% | -$44.1K |
|
2968
Cogent Biosciences
COGT
$6.59B
| $790K | ﹤0.01% |
93,891
-60
| -0.1% | -$460 |
|
2969
Rio Tinto
RIO
$165B
| $783K | ﹤0.01% |
11,715
-163
| -1% | -$12.7K |
|
|
EBET
2970
DELISTED
EBET, INC. Common Stock
EBET
| $782K | ﹤0.01% |
+776
| New | +$627K |
|
|
FUV
2971
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $781K | ﹤0.01% |
3,416
+72
| +2% | +$19.6K |
|
2972
Seneca Foods Class A
SENEA
$1.26B
| $777K | ﹤0.01% |
16,107
-33,346
| -67% | -$1.68M |
|
2973
Aviat Networks
AVNW
$281M
| $775K | ﹤0.01% |
23,569
-87
| -0.4% | -$3.01K |
|
2974
iShares Russell Mid-Cap ETF
IWR
$57.8B
| $775K | ﹤0.01% |
9,900
| – | – |
|
2975
Rafael Holdings
RFL
$106M
| $775K | ﹤0.01% |
25,548
+607
| +2% | +$27.9K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.